Avanos Medical, INC Form 4 insider transactions
NYSE
Director Julie Ann Shimer of Avanos Medical, Inc. (AVNS) recently acquired 500 shares of common stock, increasing her beneficial ownership.
NYSE
Michael Greiner, SVP and CFO of Avanos Medical, reports acquisition and disposal of common stock and vesting of restricted share units.
NYSE
SVP, Chief Commercial Officer of Avanos Medical, Kerr Holbrook, reports acquisition and disposal of company stock related to restricted share units and tax obligations.
NYSE
John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc., reports acquisition of shares and surrender of shares to cover tax obligations related to vesting restricted share units.
NYSE
Mojirade James, SVP and General Counsel of Avanos Medical, reported the acquisition of 30,695 shares of common stock and the disposal of 1,951 shares to cover tax obligations.
NYSE
Sudhakar Varshney, SVP of Global Supply Chain at Avanos Medical, Inc., reports the surrender of shares to cover tax obligations upon vesting of restricted stock units.
NYSE
CEO Joseph Woody reports acquisition of restricted share units and disposition of shares to cover tax obligations.
NYSE
Mojirade James, SVP, General Counsel of Avanos Medical, Inc., reports the surrender of shares to cover tax obligations upon vesting of restricted share units.
NYSE
Michael Greiner, SVP and CFO of Avanos Medical, reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.
NYSE
Kerr Holbrook, SVP and Chief Commercial Officer of Avanos Medical, disposed of 1,502 shares to cover tax obligations related to vesting restricted share units.
NYSE
John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc., reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
NYSE
A Form 4 filing reveals that Avanos Medical CEO Joseph Fralin Woody sold shares to cover tax withholding obligations upon the vesting of restricted share units.